Collaboration Details

Print  Close


Title of Collaborative Activity:

Anti-Infective Drugs Advisory Committee

Description of Collaborative Activity:

This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval.

Type of Collaborative Activity:

Advisory Group

Year the Collaborative Activity Originated:

2007

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA